Ultragenyx Pharmaceutical
RARE
RARE
171 hedge funds and large institutions have $3.98B invested in Ultragenyx Pharmaceutical in 2015 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 74 increasing their positions, 51 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
20% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $12.8M
Holders
171
Holding in Top 10
2
Calls
$10.2M
Puts
$12.8M
Top Buyers
| 1 | +$47.2M | |
| 2 | +$30.9M | |
| 3 | +$24.7M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$21.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.2M |
Top Sellers
| 1 | -$43.6M | |
| 2 | -$39M | |
| 3 | -$15.9M | |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$15.8M |
| 5 |
Two Sigma Investments
New York
|
-$14.5M |